BOT Natunola Agritech, Inc.

TSX VENTURE EXCHANGE: BOT     QUEBEC CITY, QC, Nov. 29, 2011 /CNW/ - Botaneco Corp. ("Botaneco" or the "Corporation") , announces that effective immediately Mr. Aki Georgacacos has been appointed President and Chief Executive Officer (CEO), replacing Mike Stangel.  Mr. Georgacacos is a member of the Botaneco's Board of Directors and a Partner in Avrio Ventures, Canada's largest agriculture and agritech focused venture capital fund.  Mr. Georgacacos will act as President and CEO on an interim basis while the Corporation evaluates alternatives to fill the role on a permanent basis. "Having been involved with the business since 2006, Aki will move seamlessly into the President and CEO role," commented Dave Guebert, the lead independent director of Botaneco. Mr. Guebert added, "We'd like to thank Mike for the energy, and leadership he has provided for the Company. He has been integral in stabilizing operations and creating a diversified consumer health products platform poised for continued growth." About Botaneco Botaneco Corp., which includes its subsidiary Botaneco Specialty Ingredients Inc. since November 20, 2009 and its subsidiary Natunola Health Biosciences Inc. ("Natunola") since October 7, 2011, is a health sciences and technology company developing, manufacturing and marketing proprietary natural ingredients and formulations for oral and topical applications that have been clinically proven to be safe and effective for improving skin health and well being. More information is available and can be accessed at www.botaneco.ca Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  Botaneco Corp. CONTACT: Murray Bruce Hogan MullallyChief Financial Officer Investor RelationsBotaneco Corp. (888) 442-4106(403) 668-4612 hogan@bridge-relations.combrucem@botaneco.ca www.bridge-relations.com

Copyright